Comparison of ischemic and bleeding risk scores in non-ST elevation acute coronary syndromes

References

• Anderson JL, Adams CD, Antman EM, Bridges CR, Califf RM, Casey DE Jr, . ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction. Circulation 2007;116:e148–e304.
   PubMedGoogle Scholar
• Bassand JP, Hamm CW, Ardissino D, Boersma E, Budaj A, Fernandez-Aviles F, . Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes. Eur Heart J. 2007;28:1598–660.
   PubMed Web of Science ®Google Scholar
• Eikelboom JW, Mehta SR, Anand SS, Xie C, Fox KA, Yusuf S, . Adverse impact of bleeding in patients with Acute Coronary Syndromes. Circulation 2006;114;774–82.
   PubMed Web of Science ®Google Scholar
• Pocock SJ, Mehran R, Clayton TC, Nikolsky E, Parise H, Fahy M, . Prognostic modeling of individual patient risk and mortality impact of ischemic and hemorrhagic complications assessment from the acute catheterization and urgent intervention triage strategy trial. Circulation 2010;121:43–515.
   PubMed Web of Science ®Google Scholar
• Díez JG, Cohen M. Balancing myocardial ischemic and bleeding risks in patients with non-ST-segment elevation myocardial infarction. Am J Cardiol. 2009;103:1396–402.
   PubMedGoogle Scholar
• Thygesen K, Alpert JS, White HD, on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction. Universal definition of myocardial infarction. Eur Heart J. 2007;28:2525–38.
   PubMed Web of Science ®Google Scholar
• Antman EM, Cohen M, Bernink PJ, McCabe CH, Horacek T, Papuchis G, . The TIMI risk score for unstable angina/non-ST elevation MI: A method for prognostication and therapeutic decision making. JAMA 2000;284:835–42.
   PubMed Web of Science ®Google Scholar
• Granger CB, Goldberg RJ, Dabbous O, Pieper KS, Eagle KA, Cannon CP, . Predictors of hospital mortality in the global registry of acute coronary events. Arch Intern Med. 2003;163: 2345–53.
   PubMed Web of Science ®Google Scholar
• Subherwal S, Bach RG, Chen AY, Gage BF, Rao SV, Newby LK, . Baseline risk of major bleeding in non-ST-segment–elevation myocardial infarction: The CRUSADE (can rapid risk stratification of unstable angina patients suppress adverse outcomes with early implementation of the ACC/AHA guidelines) bleeding score. Circulation. 2009;119:1873–82.
   PubMed Web of Science ®Google Scholar
• Scirica BM, Cannon CP, Antman EM, Murphy SA, Morrow DA, Sabatine MS, . Validation of the thrombolysis in myocardial infarction (TIMI) risk score for unstable angina pectoris and non-ST-elevation myocardial infarction in the TIMI III registry. Am J Cardiol. 2002;90:303–5.
   PubMed Web of Science ®Google Scholar
• Stone GW, Grines CL, Browne KF, Marco J, Rothbaum D, O'Keefe J, . Implications of recurrent ischemia after reperfusion therapy in acute myocardial infarction: A comparison of thrombolytic therapy and primary angioplasty. J Am Coll Cardiol.1995;26:66–72.
   PubMed Web of Science ®Google Scholar
• DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: A nonparametric approach. Biometrics 1988;44:837–45.
   PubMed Web of Science ®Google Scholar
• Santos JF, Aguiar C, Gavina C, Azevedo P, Morais J. Portuguese registry of acute coronary syndromes: Seven years of activity. Rev Port Cardiol. 2009;28:1465–500.
   PubMedGoogle Scholar
• Abu-Assi E, Gracía-Acuña JM, Ferreira-González I, Peña-Gil C, Gayoso-Diz P; González-Juanatey JR. Evaluating the performance of the can rapid risk stratification of unstable angina patients suppress adverse outcomes with early implementation of the ACC/AHA guidelines (CRUSADE) bleeding score in a contemporary Spanish cohort of patients with non-ST-segment elevation acute myocardial infarction. Circulation. 2010;121:2419–6.
   PubMed Web of Science ®Google Scholar
• Agostoni P, Biondi-Zoccai GG, de Benedictis ML, Rigattieri S, Turri M, Anselmi M, . Radial versus femoral approach for percutaneous coronary diagnostic and interventional procedures; systematic overview and meta-analysis of randomized trials. J Am Coll Cardiol. 2004;44:349–56.
   PubMed Web of Science ®Google Scholar
• Chase AJ, Fretz EB, Warburton WP, Klinke WP, Carere RG, Pi D, . The association of arterial access site at angioplasty with transfusion and mortality: the M.O.R.T.A.L sudy: (Mortality benefit of reduced transfusion After PCI via the arm or leg). Heart 2008;94:1019–25.
   PubMed Web of Science ®Google Scholar
• Manoukian SV, Feit F, Mehran R, Voeltz MD, Ebrahimi R, Hamon M, . Impact of major bleeding on 30-day mortality and clinical outcomes in patients with acute coronary syndromes: An analysis from the ACUITY Trial. J Am Cardiol. 2007;49:1362–8.
   Web of Science ®Google Scholar
• Moscucci M, Fox KA, Cannon CP, Klein W, López-Sendón J, Montalescot G, . Predictors of major bleeding in acute coronary syndromes: The global registry of acute coronary events (GRACE). Eur Heart J. 2003;24:1815–23.
   PubMed Web of Science ®Google Scholar
• Chew DP, Lincoff AM, Gurm H, Wolski K, Cohen DJ, Henry T, . REPLACE-2 Investigators. Bivalirudin versus heparin and glycoprotein IIb/IIIa inhibition among patients with renal impairment undergoing percutaneous coronary intervention (a subanalysis of the REPLACE-2 trial). Am J Cardiol. 2005;95:581–5.
   PubMed Web of Science ®Google Scholar
• Mehran R, Pocock SJ, Nikolsky E, Clayton T, Dangas GD, Kirtane AJ, . A risk score to predict bleeding in patients with acute coronary syndromes. J Am Coll Cardiol. 2010;55:2556–66.
   PubMed Web of Science ®Google Scholar
• de Ruijter W, Westendorp RG, Assendelft WJ, den Elzen WP, de Craen AJ, le Cessie S, . Use of Framingham risk score and new biomarkers to predict cardiovascular mortality in older people: population based observational cohort study. Br Med J. 2009;338:a3083.
   PubMed Web of Science ®Google Scholar
• Boersma E, Pieper KS, Steyerberg EW, Wilcox RG, Chang WC, Lee KL, . PURSUIT investigators. Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation. Results from an international trial of 9461 patients. Circulation 2000;101;2557–67.
   PubMed Web of Science ®Google Scholar
• Joyner CD, Peters RJ, Afzal R, Chrolavicius S, Mehta SR, Fox KA, . Fondaparinux compared to enoxaparin in patients with acute coronary syndromes without ST segment elevation: outcomes and treatment effect across different levels of risk. Am Heart J. 2009;157:502–8.
   PubMed Web of Science ®Google Scholar
• Cannon CP, Weintraub WS, Demopoulos LA, Vicari R, Frey MJ, Lakkis N, . TACTICS—thrombolysis in myocardial infarction (TIMI) 18 investigators: comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med. 2001;344:1879–87.
   PubMed Web of Science ®Google Scholar
• Morrow DA, Antman EM, Snapinn SM, McCabe CH, Theroux P, Braunwald E. An integrated clinical approach to predicting the benefit of tirofiban in non-ST elevation acute coronary syndromes. Application of the TIMI Risk Score for UA/NSTEMI in PRISM-PLUS. Eur Heart J. 2002;23:223–9.
   PubMed Web of Science ®Google Scholar
• Alexander KP, Chen AY, Roe MT, Newby LK, Gibson CM, Allen-LaPointe N, . CRUSADE investigators. Excess dosing of antiplatelet and antithrombin agents in the treatment of non-ST-segment elevation acute coronary syndromes. JAMA 2005; 294:3108–16.
   PubMed Web of Science ®Google Scholar